Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Clinical trial NCT03959085 · RECRUITING

Trial details

NCT number: NCT03959085
Sponsor: Children's Oncology Group
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

B Acute Lymphoblastic Leukemia B Lymphoblastic Lymphoma Central Nervous System Leukemia Mixed Phenotype Acute Leukemia Testicular Leukemia

Start date: 2019-10-31
Primary completion: 2032-03-31
Enrollment: 5951

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.